[Problems of antibiotic administration in myasthenia gravis].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis; D009467:Neuromuscular Depolarizing Agents; D009469:Neuromuscular Junction / Q000187:drug effects*; D011113:Polymyxins / Q000009:adverse effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D013752:Tetracycline / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D009467:Neuromuscular Depolarizing Agents; D011113:Polymyxins; D013752:Tetracycline